• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Susceptibility of human influenza A (H3N2) viruses to neuraminidase inhibitors isolated during 2011-2012 in China

tetano

Editor, Senior Moderator
Zhonghua Yu Fang Yi Xue Za Zhi. 2015 Jun;49(6):481-484.
[h=1][Susceptibility of human influenza A (H3N2) viruses to neuraminidase inhibitors isolated during 2011-2012 in China].[/h] [Article in Chinese]
Huang W[SUP]1[/SUP], Tan M[SUP]1[/SUP], Zhao X[SUP]1[/SUP], Cheng Y[SUP]1[/SUP], Li X[SUP]1[/SUP], Guo J[SUP]1[/SUP], Wei H[SUP]1[/SUP], Xiao N[SUP]1[/SUP], Wang Z[SUP]1[/SUP], Wang D[SUP]2[/SUP], Shu Y[SUP]1[/SUP].
[h=3]Author information[/h]

[h=3]Abstract[/h] [h=4]OBJECTIVE:[/h] To analyze the susceptibility of influenza A (H3N2) viruses to neuraminidase inhibitors during 2011-2012 in Mainland China.
[h=4]METHODS:[/h] All the tested viruses were obtained from the Chinese National Influenza Surveillance Network, which covers 31 provinces in mainland China, including 408 network laboratories and 554 sentinel hospitals. In total 1 903 viruses were selected with isolation date from January 1, 2011 to December 31, 2012 in Mainland China, among these viruses, 721 were confirmed to be influenza A (H3N2) virus by Chinese National Influenza Center and tested for the susceptibility to oseltamivir and zanamivir using chemiluminescence-based assay. The neuraminidase inhibitor sensitive reference virus A/Washington/01/2007 (119E) and oseltamivir resistant virus A/Texas/12/2007 (E119V) were used as control in this study. The t -test was used to compare the difference of NAI susceptibility of viruses isolated from different years.
[h=4]RESULTS:[/h] The half maximal inhibitory concentration (IC[SUB]50[/SUB]) of A/Washington/01/2007 for oseltamivir and zanamivir was (0.10 ? 0.02) and (0.30 ? 0.05) nmol/L, respectively. The IC[SUB]50[/SUB] of A/Texas/12/2007 for oseltamivir and zanamivir was (4.27 ? 1.60) and (0.20 ? 0.03) nmol/L, respectively. Among the 721 influenza A (H3N2) viruses, 132 influenza A (H3N2) viruses were isolated in 2011 and 589 influenza A (H3N2) viruses were isolated in 2012. The IC[SUB]50[/SUB] for oseltamivir ranged from 0.04 to 0.62 nmol/L for viruses isolated in 2011 and ranged from 0.02 to 0.95 nmol/L for viruses in 2012, and the IC[SUB]50[/SUB] of all the viruses tested was within 10-fold IC[SUB]50[/SUB] (1.0 nmol/L) of the neuraminidase inhibitor sensitive reference virus A/Washington/01/2007. The IC[SUB]50[/SUB] of zanamivir ranged from 0.12 to 0.80 nmol/L for viruses in 2011 and ranged from 0.04 to 0.72 nmol/L for viruses in 2012, and was within 10-fold IC[SUB]50[/SUB] (3.0 nmol/L) of the neuraminidase inhibitor sensitive reference virus A/Washington/01/2007.
[h=4]CONCLUSION:[/h] The influenza A(H3N2) viruses isolated during 2011-2012 in Mainland China were tested to be sensitive to oseltamivir and zanamivir.


PMID: 26310330 [PubMed - as supplied by publisher]
 
Back
Top Bottom